Table 1 Patient characteristics by treatment
C ( n =59) | S ( n =60) | All patients ( n =119) | |
---|---|---|---|
Age (years) | |||
Median | 60 | 58 | 59 |
Range | 35–73 | 27–75 | 27–75 |
Sex (%) | |||
Male | 51 (86) | 53 (88) | 104 (87) |
Female | 8 (14) | 7 (12) | 15 (13) |
Race (%) | |||
Chinese | 45 (76) | 50 (84) | 95 (80) |
Indian | 8 (14) | 5 (8) | 13 (11) |
Malay | 6 (10) | 5 (8) | 11 (9) |
Site of disease (%) | |||
Oral cavity | 19 (32) | 13 (22) | 32 (27) |
Oropharynx | 12 (20) | 13 (22) | 25 (21) |
Hypopharynx | 7 (12) | 7 (12) | 14 (12) |
Supraglottis | 13 (22) | 14 (23) | 27 (23) |
Glottis | 5 (9) | 5 (8) | 10 (8) |
Subglottis | 0 (0) | 1 (1) | 1 (1) |
Maxillary sinus | 3 (5) | 7 (12) | 10 (8) |
Tumour status (%) | |||
T1 | 0 (0) | 5 (8) | 5 (4) |
T2 | 9 (15) | 8 (13) | 17 (14) |
T3 | 16 (27) | 15 (25) | 31 (26) |
T4 | 34 (58) | 32 (54) | 66 (56) |
Nodal status (%) | |||
N0 | 19 (32) | 17 (28) | 36 (30) |
N1 | 15 (25) | 7 (12) | 22 (19) |
N2 | 24 (41) | 31 (52) | 55 (46) |
N3 | 1 (2) | 5 (8) | 6 (5) |
TNM staging (%) | |||
Stage III | 12 (20) | 12 (20) | 24 (20) |
Stage IVA | 46 (78) | 43 (72) | 89 (75) |
Stage IVB | 1 (2) | 5 (8) | 6 (5) |